プロモーションスケジュール Clarity Pharmaceuticals Ltd
詳細なスケジュール
簡易グラフ
会社について Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. さらに詳しくIndustry | Biotechnology |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | aud |
Сайт | https://www.claritypharmaceuticals.com |
Цена ао | 5.55 |
1日あたりの価格変動: | +16.59% (2.32) |
---|---|
週ごとの価格変動: | -7.99% (2.94) |
月ごとの料金変更: | -30.48% (3.891) |
3ヶ月間の価格変動: | -54.35% (5.925) |
半年間の価格変動: | -20.21% (3.39) |
年間の価格変動: | +109.69% (1.29) |
3年間の価格推移: | 0% (2.705) |
5年間の価格推移: | 0% (2.705) |
10年間の価格推移: | 0% (2.705) |
年初からの価格変動: | -43.3% (4.771) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
機関 | 音量 | 共有, % |
---|---|---|
PFM Multi Manager Series-International Equity Fd | 24827 | 0.01 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Dr. Alan John Taylor Ph.D. | Executive Chairman | 567.72k | |
Dr. Colin David Biggin Ph.D. | MD, CEO & Executive Director | 455.18k | |
Mr. David K. Green BEc., CA | Chief Financial Officer | 159.32k | |
Mr. Shaemus Gleason | Executive Vice President of Operations | N/A | |
Dr. Matthew Harris BSc., M.B.A., Ph.D. | Chief Scientific Officer | 130.94k | |
Michelle Parker | Chief Clinical Officer | N/A | |
Mr. Robert Vickery | Company Secretary | 109.28k | |
Ms. Lisa Sadetskaya | Director of Corporate Communications. | ||
Mary Bennett | Head of Human Resource | ||
Dr. Othon Gervasio | Chief Medical Officer |
住所: Australia, Sydney, National Innovation Centre - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.claritypharmaceuticals.com
Webサイト: https://www.claritypharmaceuticals.com